Methadone: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett mNo edit summary |
imported>Robert Badgett mNo edit summary |
||
| Line 2: | Line 2: | ||
==Adverse effects== | ==Adverse effects== | ||
Methadone may prolong the [[QT interval]] leading to [[Torsades de pointes]]. | Methadone may prolong the [[QT interval]] leading to [[Torsades de pointes]]. [[Clinical practice guideline]]s address screening for abnormal QT intervals.<ref name="pmid19153406">{{cite web |url=http://www.annals.org/cgi/content/full/0000605-200903170-00103v1 |title=QTc Interval Screening in Methadone Treatment |authorKrantz et al= |authorlink= |coauthors= |date=2009 |format= |work= |publisher=Annals of Internal Medicine |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=}}</ref> | ||
==References== | ==References== | ||
Revision as of 10:02, 20 January 2009
In pharmacology, methadone is a a "synthetic opioid that is used as the hydrochloride. It is an opioid analgesic that is primarily a mu-opioid agonist. It has actions and uses similar to those of morphine. It also has a depressant action on the cough center and may be given to control intractable cough associated with terminal lung cancer. Methadone is also used as part of the treatment of dependence on opioid drugs, although prolonged use of methadone itself may result in dependence. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1082-3)."[1]
Adverse effects
Methadone may prolong the QT interval leading to Torsades de pointes. Clinical practice guidelines address screening for abnormal QT intervals.[2]
References
- ↑ Anonymous (2024), Methadone (English). Medical Subject Headings. U.S. National Library of Medicine.
- ↑ QTc Interval Screening in Methadone Treatment. Annals of Internal Medicine (2009).